GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 6860N
GlaxoSmithKline PLC
01 February 2016
 

GlaxoSmithKline plc

 

 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibilities or Connected Persons

 

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the 'Plan') notified GlaxoSmithKline plc ('GSK') on 28 January 2016 that the under-mentioned Directors, Persons Discharging Managerial Responsibilities ('PDMR') and Connected Persons acquired notional Ordinary Shares at a price of 1380.50 pence per Ordinary Share and American Depositary Shares ('ADSs') at a price of $40.28 per ADS, following the notional re-investment of the dividend paid to shareholders on 14 January 2016.

 

Director/PDMR

Ordinary Shares

ADSs

Sir Andrew Witty

19,386.598


Dr M M Slaoui


5,593.782

Mr S Dingemans

8,420.745


Mr R G Connor

3,776.009


Mr N Hirons

605.055

205.414

Mr S A Hussain

7,915.467


Mr D S Redfern

2,871.479


Ms C Thomas

3,990.411


Mr P C Thomson

2,037.648


Mr D E Troy


3,479.925

Dr P J T Vallance

8,497.018


Ms E Walmsley

5,746.265


Mrs V A Whyte

535.716


 

 

 

Connected Person

 

Ordinary Shares

 

       ADSs

Dr K Slaoui (Connected Person to Dr M M Slaoui)


90.488

Mrs K Thomson (Connected Person to Mr P C Thomson)

50.565


 

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).

 

 

V A Whyte

Company Secretary

1 February 2016

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEFLFBQLFXBBV